Aroflo Side Effects

As Aroflo HFA inhaler contains salmeterol and fluticasone propionate, the type and severity of adverse reactions associated with each of the compounds may be expected. There is no incidence of additional adverse events following concurrent administration of the 2 compounds. The pharmacological side effects of β₂-agonist treatment eg, tremor, palpitations and headache have been reported but tend to be transient and reduce with regular therapy. Cardiac arrythmia may occur. There have been reports of arthralgia and hypersensitivity reactions including rash, oedema and angioedema. There have been reports of oropharyngeal irritation.
Due to the fluticasone propionate component, hoarseness and candidiasis (thrush) of the mouth and throat can occur in some patients. Both hoarseness and incidence of candidiasis may be relieved by gargling with water after using Aroflo. Symptomatic candidiasis can be treated with topical antifungal therapy while still continuing with the Aroflo HFA inhaler. Possible systemic effects in children include adrenal suppression, growth retardation, decrease in bone mineral density.